<\/p>\n<\/div><\/section><\/div>
<\/p>\n<\/div><\/section> The UK’s Secretary of State for Science, Innovation and Technology, Michelle Donelan, has appointed Professor Patrick Chinnery as the next Executive Chair of the Medical Research Council (MRC). He will succeed the current interim Executive Chair of MRC, Professor John Iredale and is expected to start in October. \u201cProfessor Chinnery brings a wealth of experience as a practicing clinician and an already established and valued member of the Medical Research Council,\u201d Donelan said.<\/strong><\/p>\n <\/p>\n \u201cBy heading up one of the UK\u2019s key public funding bodies for medical research, he will spearhead delivery of high-quality training and fellowships for researchers and funding for life-changing discoveries that are so crucial to our country\u2019s health and wellbeing.<\/p>\n \u201cI also pay tribute to Professor John Iredale for his work as interim Executive Chair and thank him for his invaluable service.\u201d<\/p>\n Prof. Chinnery is currently the MRC\u2019s Director of Clinical Sciences and Professor of Neurology at Cambridge. He is also an Honorary Consultant Neurologist at Cambridge University Hospitals NHS Trust. Prof. Chinnery\u2019s key research interest concerns the role of mitochondria in human disease and investigating ways \u202fto develop new treatments for mitochondrial disorders.<\/p>\n UKRI Chief Executive Dame Ottoline Leyser commented: \u201cProf. Chinnery is an exceptional leader who will play a key role in the continued development of UKRI \u202fand the Medical Research Council, ensuring it maintains its pivotal role in driving excellence in the biomedical and health sciences.<\/p>\n \u201cHe brings a great breadth of experience from across the medical sciences combined with a deep knowledge of the organisation from his time as MRC\u2019s Director of Clinical Sciences. I look forward to continuing to work with him in his new role.<\/p>\n Commenting on his appointment, Prof. Chinnery said: \u201cOpportunities to advance human health through research have never been greater, and the UK is in a very strong position globally. It will be a real privilege to lead the MRC at this exciting time, working with colleagues in UKRI and across the sector to deliver scientific and clinical impact.\u201d<\/p>\n As MRC Executive Chair, Prof. Chinnery will oversee the Council\u2019s full range of funding programmes and be responsible for its annual core budget alongside infrastructure and other cross-cutting UKRI funding allocated to the MRC. He will be responsible for MRC\u2019s portfolio of institutes as well as for the Council\u2019s wider role in providing training and support for the UK medical research community.<\/p>\n Prof. Chinnery will also join the other UKRI Executive Chairs as a member of the UKRI senior leadership team and will work closely with them, UKRI\u2019s Chief Executive and the UKRI Board to collectively manage and oversee UKRI\u2019s strategy, funding programmes and infrastructure.<\/p>\n Professor Anne Ferguson-Smith, Pro-Vice Chancellor for Research at the University of Cambridge, welcomed the appointment, saying: \u201cThese are important times for the MRC as it continues to invest in fundamental discovery research in the life sciences, experimental medicine and the translation of both to the clinic. His is an excellent appointment and we wish Patrick all the very best as he takes the helm at the MRC.\u201d<\/p>\n<\/div><\/section> Professor Patrick Chinnery <\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":" The UK’s Secretary of State for Science, Innovation and Technology, Michelle Donelan, has appointed Professor Patrick Chinnery as the next Executive Chair of the Medical Research Council (MRC). He will succeed the current interim Executive Chair of MRC, Professor John Iredale and is expected to start in October. \u201cProfessor Chinnery brings a wealth of experience […]<\/p>\n","protected":false},"author":3,"featured_media":18055,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-18054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-e-news"],"_links":{"self":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/18054"}],"collection":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/comments?post=18054"}],"version-history":[{"count":1,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/18054\/revisions"}],"predecessor-version":[{"id":18056,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/18054\/revisions\/18056"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media\/18055"}],"wp:attachment":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media?parent=18054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/categories?post=18054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/tags?post=18054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nLeading Cambridge neuroscientist appointed as Executive Chair of UK\u2019s Medical Research Council<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\n
\n
\n
\n
\n\u00a9University of Cambridge<\/p>\n<\/div><\/section>
\nShare this<\/h5>